Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-203-4 | CAS number: 104-45-0
Endpoint summary
Administrative data
Description of key information
The available data include two acute oral toxicity studies in rats.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1964
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
-
Principle of test: LD50 test in the rat.
LD50s were calculated using the Litchfield and Wilcoxon method. No further details reported. - GLP compliance:
- no
- Test type:
- other: Not specified
- Limit test:
- no
- Specific details on test material used for the study:
- The test substance was reported as 'dihydroanethole (1-methoxy-4-propylbenzene)'. No further details reported.
- Species:
- rat
- Strain:
- Osborne-Mendel
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Young adults, fasted for approximately 18 hours prior to treatment had access to water at all times and food was replaced after dosing.
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- VEHICLE
No vehicle was used in this study. The test substance was adminsitered undiluted.
CLASS METHOD
- Rationale for the selection of the starting dose: Justification of the starting dose was not provided. - Doses:
- No details reported.
- No. of animals per sex per dose:
- Groups of 10 rats (5 males and 5 females).
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: The typical observation period of 2 weeks after adminsitration. If no effects were seen during early phases of observation, animals were only monitored for 1 week.
- Necropsy of survivors performed: Not specified
- Other examinations performed: clinical signs, body weight - Statistics:
- LD50s were calculated using the Litchfield and Wilcoxon method.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 4 400 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 1.9
- Mortality:
- Death time = 4 hrs - 3 days
- Clinical signs:
- other: Depression, wet posterior.
- Gross pathology:
- No details reported.
- Other findings:
- No details reported.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- An oral LD50 of 4400 mg/kg bw in rats has been reported. Therefore, the test item is not classificable for acute toxicity according to CLP criteria (EC Regulation 1272/2008).
- Executive summary:
An oral LD50 of 4400 mg/kg bw in rats has been reported. Therefore, the test item is not classificable for acute toxicity according to CLP criteria (EC Regulation 1272/2008).
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1964
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Principle of test:
LD50 test in the rat.
LD50's calcuated using the Litchfield and Wilcocon method. No further details reported. - GLP compliance:
- no
- Test type:
- fixed dose procedure
- Limit test:
- no
- Specific details on test material used for the study:
- The test substance is reported under the alternative name 'dihydroanethole (1-methoxy-4-propylbenzene)'. No further details reported.
- Species:
- rat
- Strain:
- other:
- Remarks:
- Osborne Mendel or Sherman strain used (specific strain details not reported).
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Not reported
- Females (if applicable) nulliparous and non-pregnant: Not reported
- Age at study initiation: Reported as 'young'. No further details available.
- Weight at study initiation: 180-350 g
- Fasting period before study: 18 hours
- Housing: Not reported
- Diet (e.g. ad libitum): Not reported
- Water (e.g. ad libitum): Not reported
- Acclimation period: Not reported
No details on evironmental conditions were reported. - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- VEHICLE
The test item was administered undiluted. No vehicle was used.
MAXIMUM DOSE VOLUME APPLIED: Not reported
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: No starting dose justification was provided. - Doses:
- No details reported
- No. of animals per sex per dose:
- 5
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: Rats were observed until survivors retunred to normal weight and appearance.
- Frequency of observations and weighing: No details reported
- Necropsy of survivors performed: No details reported
- Other examinations performed: clinical signs and body weight - Statistics:
- LD50s were computed by Litchfield and Wilcoxon method.
- Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 4 400 mg/kg bw
- 95% CL:
- 1.9
- Mortality:
- Death time: 4 hrs - 3 days
- Clinical signs:
- other: Depression, porphyrin-like deposit around eyes and nose, wet posterior
- Gross pathology:
- No details reported.
- Other findings:
- In a follow-up study, histopathological examination fo the liver of rats (3/sex/dose) administered dihydroanethole an acute dose of 1470 mg/kg. Results gave a rating of 0.5 = liver had 1 or 2 necrotic lesions grayish or yellow in colour.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- An oral LD50 of 4400 mg/kg bw in rats has been reported. Therefore, the test item is not classificable for acute toxicity according to CLP criteria (EC Regulation 1272/2008).
- Executive summary:
An oral LD50 of 4400 mg/kg bw in rats has been reported. Therefore, the test item is not classificable for acute toxicity according to CLP criteria (EC Regulation 1272/2008).
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 4 400 mg/kg bw
- Quality of whole database:
- Both of the studies are considered to have a reliability score of 2.
Additional information
Justification for classification or non-classification
An oral LD50 of 4400 mg/kg bw in rats has been reported. Therefore, the test item is not classificable for acute toxicity according to CLP criteria (EC Regulation 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
